Güner Hayri Özcan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Fludarabine-containing combinations have additive cell killing against leukemic blasts in vitro. It has also been shown that imatinib mesylate combined with fludarabine or cladribine had an additive effect on CML CFU-GM cells. In this regard, we aimed to investigate the effect of fludarabine-imatinib mesylate combination against CML blastic phase cell lines(More)
  • 1